Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;47(2):227-234.
doi: 10.1097/DSS.0000000000002911.

A Systematic Review Supporting the American Society for Dermatologic Surgery Guidelines on the Prevention and Treatment of Adverse Events of Injectable Fillers

Tarek Nayfeh  1   2 , Sahrish Shah  1   2 , Konstantinos Malandris  1   2 , Mustapha Amin  1   2 , Rami Abd-Rabu  1   2 , Mohamed O Seisa  1   2 , Samer Saadi  1   2 , Rami Rajjoub  1   2 , Mohammed Firwana  1   2 , Larry J Prokop  3 , Mohammad H Murad  1   2
Affiliations

A Systematic Review Supporting the American Society for Dermatologic Surgery Guidelines on the Prevention and Treatment of Adverse Events of Injectable Fillers

Tarek Nayfeh et al. Dermatol Surg. .

Abstract

Background: As the use of injectable skin fillers increase in popularity, an increase in the reported adverse events is expected.

Objective: This systematic review supports the development of American Society for Dermatologic Surgery practice guideline on the management of adverse events of skin fillers.

Methods and materials: Several databases for studies on risk factors or treatments of injection-related visual compromise (IRVC), skin necrosis, inflammatory events, and nodules were searched. Meta-analysis was conducted when feasible.

Results: The review included 182 studies. However, IRVC was very rare (1-2/1,000,000 patients) but had poor prognosis with improvement in 19% of cases. Skin necrosis was more common (approximately 5/1,000) with better prognosis (up to 77% of cases showing improvement). Treatments of IRVC and skin necrosis primarily depend on hyaluronidase injections. Risk of skin necrosis, inflammatory events, and nodules may be lower with certain fillers, brands, injection techniques, and volume. Treatment of inflammatory events and nodules with antibiotics, corticosteroids, 5-FU, and hyaluronidase was associated with high response rate (75%-80%). Most of the studies were small and noncomparative, making the evidence certainty very low.

Conclusion: Practitioners must have adequate knowledge of anatomy, elicit history of skin filler use, and establish preemptive protocols that prepare the clinical practice to manage complications.

PubMed Disclaimer

References

    1. ASDS. Press Release: ASDS Members Performed More Than 12.5 Million Treatments in 2018. Available from: https://www.asds.net/Skin-Experts/News-Room/Press-Releases/ASDS-Members-... . Accessed August 24, 2020.
    1. Povolotskiy R, Oleck NC, Hatzis CM, Paskhover B. Adverse events associated with aesthetic dermal fillers: a 10-year retrospective study of FDA data. Am J Cosmet Surg 20182018;35:143–51.
    1. Lafaille P, Benedetto A. Fillers: contraindications, side effects and precautions. J Cutan Aesthet Surg 2010;3:16–9.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
    1. Viswanathan M, Patnode CD, Berkman ND, Bass EB, et al. Recommendations for assessing the risk of bias in systematic reviews of health-care interventions. J Clin Epidemiol 2018;97:26–34.

Publication types

MeSH terms